In this study, we used anti-S1333 ROCKI and anti-S1366 ROCKII antibodies to inform the ROCKI and ROCKII kinase activation status in different types of breast cancer and found that ROCKII activation signal detected in nuclei was significantly correlated with tumor metastasis. This evidence concerns the gene ROCK2 and breast cancer.